Advertisement
Advertisement
U.S. Markets close in 3 hrs 24 mins
Advertisement
Advertisement
Advertisement
Advertisement

HAVN Life Sciences Inc. (HAVN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2050+0.0100 (+5.13%)
As of 11:47AM EST. Market open.
Advertisement

HAVN Life Sciences Inc.

2200 - 885 West Georgia Street
Vancouver, BC V6C 3E8
Canada
604 359 0060
http://www.havnlife.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Tim MooreCEO & Director144kN/A1959
Mr. Eli Seamus-Sweet Dusenbury C.A., CPA, CPA, CAChief Financial Officer150kN/A1983
Ms. Jenna PozarChief Operating OfficerN/AN/AN/A
Ms. Susan ChapelleExec. Vice-Pres of R&DN/AN/AN/A
Mr. Gary Joseph LeongChief Science OfficerN/AN/A1965
Dr. Ivan CasselmanChief Psychedelics OfficerN/AN/AN/A
Mr. Alexzander SamuelssonChief Research OfficerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was founded in 2020 and is headquartered in Vancouver, Canada.

Corporate Governance

HAVN Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement